Series: Ask the IRB & IBC Experts
WCG’s IRB & IBC Review professionals get questions about clinical research all the time: from researchers, clinical team members at biopharma companies, and from members of institutional IRBs. We know that for many of the questions, the person asking is not the only one struggling with that issue. We’ve built this forum as an immediate and less formal way to share information across the clinical research community.
Ethics in Clinical Research
Ask the Experts: What Is E-consent? What Are E-signatures?
Blog Posts
Series: Ask the IRB & IBC Experts
Ask the Experts: What is the difference between a Risk Group and a Biosafety Level?
Blog Posts
Ethics in Clinical Research
What Information Must Be Included in the Cost Section of an Informed Consent Form?
Blog Posts
Ethics in Clinical Research
What Is Assent, When Provided by an Adult Participant Lacking Capacity? And What Are WCG’s Expectations and the Investigator’s Responsibilities?
Blog Posts
Ethics in Clinical Research
Why Was My Research Submission/Protocol Deferred? And What Should I Do?
Blog Posts
Ethics in Clinical Research
If My Study Includes Approved Drugs, When Do the Risks of Those Drugs Need to Be Disclosed in the Consent Form?
Blog Posts
Series: Ask the IRB & IBC Experts
IRB Submission Requirements for Decentralized Clinical Trials
Blog Posts
Ethics in Clinical Research
Post Study Activities Requiring IRB Review
Blog Posts
Ethics in Clinical Research
What is the WCG IRB’s current process for reviewing research involving children as subjects that is not otherwise approvable by an IRB?
Blog Posts
Ethics in Clinical Research